دورية أكاديمية
أعرض في EDS

Research Progress on the Experimental Model and Underlying Mechanistic Studies of Tension-Type Headaches.

التفاصيل البيبلوغرافية
العنوان: Research Progress on the Experimental Model and Underlying Mechanistic Studies of Tension-Type Headaches.
المؤلفون: Fu GJ; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China., Wang LD; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China., Chi XS; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China., Liang X; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China., Wei JJ; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China., Huang ZH; Yidu Central Hospital of Weifang, Weifang, 262,550, China., Shen W; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China. 676665709@qq.com., Zhang YL; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100,091, China. yunlingzhang2004@126.com.
المصدر: Current pain and headache reports [Curr Pain Headache Rep] 2024 May; Vol. 28 (5), pp. 439-451. Date of Electronic Publication: 2024 Mar 19.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Current Science Inc Country of Publication: United States NLM ID: 100970666 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-3081 (Electronic) Linking ISSN: 15343081 NLM ISO Abbreviation: Curr Pain Headache Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Philadelphia, PA : Current Science Inc., c2001-
مواضيع طبية MeSH: Tension-Type Headache*/physiopathology , Tension-Type Headache*/drug therapy , Tension-Type Headache*/therapy , Disease Models, Animal*, Animals ; Humans
مستخلص: Purpose of Review: Tension-type headaches (TTH) significantly diminish patients' quality of life and increase absenteeism, thereby imposing a substantial economic burden. Animal models are essential tools for studying disease mechanisms and drug development. However, until now, little focus has been placed on summarizing the animal models of TTH and associated mechanistic studies. This narrative review discusses the current animal models of TTH and related mechanistic studies to provide insights into the pathophysiological mechanisms of and treatments for TTH.
Recent Findings: The primary method for constructing an animal model of TTH involves injecting a solution of pain relievers, such as adenosine triphosphate, nerve growth factor, or a high concentration of salt solution, into the neck to initiate harmful cervical muscle responses. This model enables the examination of the interaction between peripheral muscles and central sensitization, which is crucial for understanding the pathophysiology of TTH. Mechanistic studies based on this model have investigated the effect of the P2X receptor antagonist, P2X7 receptor blockade, the P2Y1 receptor agonist 2-MESADP, P2Y1 receptor antagonist MRS2179, nitric oxide synthase inhibitors, and acetylsalicylic acid. Despite notable advancements, the current model of TTH has limitations, including surgical complexity and the inability to replicate chronic tension-type headache (CTTH). To gain a more comprehensive understanding and develop more effective treatment methods, future studies should focus on simplifying surgical procedures, examining other predisposing factors, and establishing a model for chronic TTH. This will offer a deeper insight into the pathophysiological mechanism of TTH and pave the way for improved treatment approaches.
(© 2024. The Author(s).)
References: Stem Cell Rev Rep. 2017 Jun;13(3):381-406. (PMID: 28488234)
PLoS One. 2016 Oct 26;11(10):e0165316. (PMID: 27783660)
Eur J Neurosci. 2007 Mar;25(5):1297-306. (PMID: 17425556)
Pain. 2000 Jan;84(1):29-36. (PMID: 10601670)
FEBS Lett. 2008 Nov 26;582(28):3948-53. (PMID: 18977353)
Exp Neurol. 2005 Feb;191(2):301-9. (PMID: 15649485)
Women Health. 2018 Oct;58(9):1037-1049. (PMID: 28922097)
Pain. 1999 May;81(1-2):115-28. (PMID: 10353499)
Trends Neurosci. 2018 Jan;41(1):31-46. (PMID: 29223312)
Pain. 2003 Jul;104(1-2):241-7. (PMID: 12855334)
J Headache Pain. 2016;17:40. (PMID: 27093871)
Pharmacol Ther. 2022 Feb;230:107959. (PMID: 34265360)
Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):310-23. (PMID: 11111826)
Women Health. 2020 Jul;60(6):652-663. (PMID: 31795922)
J Pain. 2009 Sep;10(9):895-926. (PMID: 19712899)
J Appl Physiol (1985). 2003 Aug;95(2):577-83. (PMID: 12716867)
Curr Rheumatol Rep. 2014 Jan;16(1):395. (PMID: 24264721)
Dtsch Arztebl Int. 2008 Mar;105(12):214-9. (PMID: 19629211)
Cephalalgia. 2007 Nov;27(11):1226-35. (PMID: 17850351)
Neurosci Lett. 2003 Feb 20;338(1):25-8. (PMID: 12565132)
Cephalalgia. 2010 Oct;30(10):1225-32. (PMID: 20855368)
Br J Anaesth. 2000 Apr;84(4):476-88. (PMID: 10823099)
Circulation. 2005 May 31;111(21):2748-51. (PMID: 15911708)
Pain. 2008 Jul;137(1):81-95. (PMID: 17900807)
Eur J Pharmacol. 1992 Jul 7;217(2-3):217-9. (PMID: 1330591)
Br J Pharmacol. 2007 May;151(2):226-36. (PMID: 17351651)
Cephalalgia. 2015 Mar;35(3):211-9. (PMID: 24853166)
Cephalalgia. 2005 Feb;25(2):109-16. (PMID: 15658947)
J Neurosci. 2004 Jan 28;24(4):797-807. (PMID: 14749424)
Pain. 1996 Aug;66(2-3):313-9. (PMID: 8880855)
Cephalalgia. 2009 Jan;29(1):58-67. (PMID: 19126119)
Brain Res. 2001 Dec 7;921(1-2):233-9. (PMID: 11720731)
Dis Mon. 2017 Dec;63(12):342-367. (PMID: 28886861)
J Appl Physiol (1985). 2005 Nov;99(5):1977-84. (PMID: 16037403)
Cephalalgia. 2004 Aug;24(8):657-62. (PMID: 15265054)
Mol Pharmacol. 2003 Oct;64(4):785-95. (PMID: 14500734)
Br J Pharmacol. 1998 Sep;125(2):341-6. (PMID: 9786507)
Clin J Pain. 2007 Jan;23(1):23-7. (PMID: 17277641)
Int J Mol Sci. 2023 May 02;24(9):. (PMID: 37175845)
Pain. 2008 Jul 31;137(3):623-630. (PMID: 18061350)
BMC Neurol. 2012 Aug 25;12:82. (PMID: 22920541)
Front Neurol. 2019 Jul 30;10:793. (PMID: 31417482)
Physiol Rev. 2007 Apr;87(2):659-797. (PMID: 17429044)
Neurochem Int. 2017 Feb;103:24-35. (PMID: 28027922)
Cereb Cortex. 2018 Aug 1;28(8):2959-2975. (PMID: 29771288)
J Neurophysiol. 1996 Sep;76(3):1924-41. (PMID: 8890304)
Pain. 1999 Feb;79(2-3):201-5. (PMID: 10068165)
Cephalalgia. 2006 Feb;26(2):128-35. (PMID: 16426266)
Curr Pain Headache Rep. 2003 Dec;7(6):466-74. (PMID: 14604506)
J Headache Pain. 2017 Sep 12;18(1):95. (PMID: 28900887)
J Manipulative Physiol Ther. 2018 Jul - Aug;41(6):483-487. (PMID: 30098821)
J Med Chem. 2009 May 28;52(10):3366-76. (PMID: 19397270)
Brain Res. 2008 Feb 15;1194:45-55. (PMID: 18177631)
Pain. 1989 Jul;38(1):17-24. (PMID: 2506503)
Headache. 2011 May;51(5):734-43. (PMID: 21434910)
J Headache Pain. 2007 Feb;8(1):49-55. (PMID: 17192817)
J Headache Pain. 2011 Apr;12(2):201-17. (PMID: 21181425)
Headache. 2007 May;47(5):662-72. (PMID: 17501847)
Clin J Pain. 2001 Mar;17(1):2-10. (PMID: 11289084)
Neuroscience. 2007 Jun 8;146(4):1817-28. (PMID: 17478048)
Brain Res Brain Res Protoc. 2003 Jul;11(3):178-88. (PMID: 12842223)
Physiol Rev. 2002 Oct;82(4):1013-67. (PMID: 12270951)
Cephalalgia. 2007 May;27(5):383-93. (PMID: 17359516)
Brain Behav Immun. 2010 Oct;24(7):1176-89. (PMID: 20554014)
Arch Phys Med Rehabil. 2008 Jan;89(1):16-23. (PMID: 18164325)
Neurotherapeutics. 2020 Jul;17(3):826-838. (PMID: 33009633)
J Headache Pain. 2019 May 21;20(1):57. (PMID: 31113373)
Cephalalgia. 2012 Feb;32(3):241-9. (PMID: 22250208)
Am J Med. 1983 Jun 14;74(6A):36-42. (PMID: 6344625)
Cephalalgia. 2000 Jun;20(5):486-508. (PMID: 11037746)
Neurochem Res. 2021 Aug;46(8):2143-2153. (PMID: 34014488)
Pain. 2012 Mar;153(3):602-618. (PMID: 22192712)
Cephalalgia. 2004 Mar;24(3):161-72. (PMID: 15009009)
Anesth Analg. 2007 Apr;104(4):927-35. (PMID: 17377109)
Pain Pract. 2019 Jun;19(5):522-529. (PMID: 30756467)
Eur J Pharmacol. 2011 Dec 30;673(1-3):13-9. (PMID: 22032900)
Brain. 1999 Sep;122 ( Pt 9):1629-35. (PMID: 10468503)
Expert Opin Pharmacother. 2002 Apr;3(4):395-9. (PMID: 11934342)
Eur J Pain. 2003;7(2):145-53. (PMID: 12600796)
Cephalalgia. 2010 Jan;30(1):1-16. (PMID: 19614696)
Cephalalgia. 2012 May;32(7):544-53. (PMID: 22529194)
Pain. 1997 Sep;72(3):355-66. (PMID: 9313276)
Trends Pharmacol Sci. 2005 Oct;26(10):496-502. (PMID: 16125256)
Int J Tissue React. 1986;8(4):327-31. (PMID: 3091522)
Br J Pharmacol. 1997 Sep;122(2):365-71. (PMID: 9313948)
Nat Rev Dis Primers. 2021 Mar 25;7(1):24. (PMID: 33767185)
Clin J Pain. 2007 May;23(4):346-52. (PMID: 17449996)
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9864-9. (PMID: 17525149)
Annu Rev Pharmacol Toxicol. 2004;44:371-97. (PMID: 14744251)
Eur J Pain. 2016 Feb;20(2):166-75. (PMID: 26147739)
Prog Neurobiol. 2001 Oct;65(2):107-34. (PMID: 11403876)
Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):340-50. (PMID: 11111828)
Pain. 2002 Jan;95(1-2):41-7. (PMID: 11790466)
Curr Pain Headache Rep. 2007 Dec;11(6):449-53. (PMID: 18173980)
Mol Neurodegener. 2014 May 03;9:17. (PMID: 24885281)
J Appl Physiol (1985). 2019 Jan 1;126(1):160-169. (PMID: 30307819)
J Neurosci. 1998 Sep 1;18(17):7008-14. (PMID: 9712669)
Eur J Pharmacol. 2005 Oct 3;521(1-3):34-8. (PMID: 16181623)
Nat Rev Neurosci. 2006 Jun;7(6):423-36. (PMID: 16715052)
Curr Neurol Neurosci Rep. 2019 May 30;19(7):44. (PMID: 31144052)
Headache. 2006 Mar;46(3):454-60. (PMID: 16618263)
Brain Res. 2008 Mar 14;1199:74-81. (PMID: 18302958)
Semin Neurol. 2018 Apr;38(2):182-190. (PMID: 29791944)
Eur J Pharmacol. 2010 Nov 25;647(1-3):55-61. (PMID: 20813105)
Neuroscientist. 2011 Jun;17(3):256-73. (PMID: 20360599)
Pain. 2005 Apr;114(3):386-396. (PMID: 15777864)
J Headache Pain. 2016 Dec;17(1):75. (PMID: 27565510)
Neurol Sci. 2008 May;29 Suppl 1:S93-5. (PMID: 18545906)
Acta Biomater. 2017 May;54:35-44. (PMID: 28315813)
Neuroreport. 1998 Mar 9;9(4):589-92. (PMID: 9559921)
Pain. 1999 May;81(1-2):7-14. (PMID: 10353488)
Cephalalgia. 2006 Jun;26(6):697-706. (PMID: 16686909)
Nat Rev Neurosci. 2003 Apr;4(4):299-309. (PMID: 12671646)
Neuroreport. 2001 Oct 8;12(14):3077-80. (PMID: 11568640)
Cephalalgia. 2003 Feb;23(1):59-66. (PMID: 12534583)
Lancet. 1999 Jan 23;353(9149):287-9. (PMID: 9929022)
Biotechnol Bioeng. 2011 Sep;108(9):2241-5. (PMID: 21391208)
Curr Pain Headache Rep. 2005 Dec;9(6):415-22. (PMID: 16282042)
Curr Pain Headache Rep. 2006 Dec;10(6):463-6. (PMID: 17087873)
Arq Neuropsiquiatr. 2019 Nov;77(11):768-774. (PMID: 31826132)
Curr Pain Headache Rep. 2011 Dec;15(6):438-43. (PMID: 21861098)
J Physiol. 2004 Jan 15;554(Pt 2):301-8. (PMID: 12832496)
فهرسة مساهمة: Keywords: Adenosine triphosphate; Animal model; Nerve growth factor; Pathophysiology; Tension-type headache
تواريخ الأحداث: Date Created: 20240319 Date Completed: 20240525 Latest Revision: 20240628
رمز التحديث: 20240629
مُعرف محوري في PubMed: PMC11126509
DOI: 10.1007/s11916-024-01238-2
PMID: 38502437
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-3081
DOI:10.1007/s11916-024-01238-2